enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Meclofenoxate - Wikipedia

   en.wikipedia.org/wiki/Meclofenoxate

   Meclofenoxate (INN, BAN; brand name Lucidril, also known as centrophenoxine) is a cholinergic nootropic used as a dietary supplement. [2] [3] [4] It is an ester of dimethylethanolamine (DMAE) and 4-chlorophenoxyacetic acid (pCPA). In elderly patients, meclofenoxate has been shown to improve performance on certain memory tests. [5]

3. Extended cycle combined hormonal contraceptive - Wikipedia

   en.wikipedia.org/wiki/Extended_cycle_combined...

   Lybrel is produced by Wyeth Pharmaceuticals. It contains 90 μg levonorgestrel and 20 μg ethinylestradiol in each pill, and is designed to be taken continuously with no placebos. [29] The FDA approved Lybrel for human consumption on May 22, 2007. [29]

4. Nootropic - Wikipedia

   en.wikipedia.org/wiki/Nootropic

   [11] [12] In 2019, the FDA and FTC warned manufacturers and consumers about possible advertising fraud and marketing scams concerning nootropic supplements. [ 3 ] [ 4 ] Over the years 2010 to 2019, the FDA warned numerous supplement manufacturers about the illegal status of their products as unapproved drugs with no proven safety or efficacy at ...

5. What is Compounded Tirzepatide? Here's What You Need to Know

   www.aol.com/compounded-tirzepatide-heres-know...

   It’s FDA-approved to help people with type 2 diabetes manage their blood sugar levels. It’s also often prescribed off-label for weight loss. It’s also often prescribed off-label for weight loss.

6. How a new FDA-approved drug can — and can’t — help people ...

   www.aol.com/fda-approved-drug-t-help-121600044.html

   Amyloid plaque is a substance that may lead to tissue loss in parts of the brain related to memory, thinking, and learning. ... If the FDA approves donanemab, it could come later this year. But ...

7. FDA approves Alzheimer’s treatment that has been shown to ...

   www.aol.com/news/fda-approves-alzheimer...

   The FDA approved a new Alzheimer’s drug that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities. The FDA approved a new Alzheimer’s drug that has ...